#USA #LabConnect #Johnson City, Tennessee #vivo #OmniScience

LabConnect and OmniScience Unveil Groundbreaking AI Solution

In a significant move toward enhancing the landscape of clinical trials, LabConnect, a leading global provider of central laboratory services, has announced a strategic partnership with OmniScience to introduce an innovative agent-based AI solution. This collaboration aims to transform the way sponsors of clinical trials leverage laboratory data, allowing them to derive actionable insights in real time.

With the integration of their technologies, LabConnect and OmniScience are set to change the dynamics of data management and decision-making in clinical studies. The new AI-driven platform, known as Vivo, acts as a control tower that consolidates fragmented lab datasets and automates monitoring processes. This advancement is pivotal in overcoming the challenges posed by isolated and complex lab data, which historically contributed to delays and heightened risks in decision-making.

Enhancing Decision-Making through Integration

The partnership focuses on streamlining the workflow of clinical trials, providing sponsors with a robust solution to enhance both the speed and quality of their research outcomes. Typically, lab data from clinical studies is siloed, complex, and difficult to interpret. The tailored AI solutions offered by OmniScience address these challenges directly by ensuring that lab data becomes integrated and easily accessible.

Angela Holmes, CEO and Co-Founder of OmniScience, emphasizes that the aim is to enable study teams to recognize and respond to insights quicker than ever before. She notes, "Our partnership with LabConnect empowers clinical teams to transform lab data into real-time, trustworthy information that enhances operational efficiency."

Wes Wheeler, CEO of LabConnect, outlines the beneficial impact of this collaboration: "At LabConnect, we empower clinical trial sponsors to unlock the full potential of their lab data. By incorporating OmniScience's transformative AI, we convert static lab results into dynamic, actionable information. Together, we provide clinical operations teams with the necessary speed, flexibility, and precision to make smarter decisions and expedite study processes."

Introducing Vivo: A New Era in Clinical Trials

Vivo, the AI-developed platform at the heart of this partnership, is crafted to transform how clinical teams interact with data throughout the drug development lifecycle. It effectively unifies disparate data sources and delivers real-time insights critical for swift decision-making. The platform integrates the operational, safety, and data science teams, enabling cohesive collaboration.

Moreover, a specialized version of Vivo, called Vivo-Lab, is tailored to further enhance management of lab data. This feature enables teams to detect trends, anomalies, and deviations at the site level as they arise, shifting monitoring from a reactive to a proactive stance. This capability is essential in managing one of the most complex and variable data streams encountered in clinical research.

Commitment to Clinical Innovations

The partnership also signifies a strong commitment by both organizations towards innovation in clinical development, marrying LabConnect's technology-driven lab workflows with OmniScience's AI-centric approach to trial intelligence. LabConnect's reputation as a premier provider of central laboratory services serves as a solid foundation for this initiative, while OmniScience's recognition, including accolades from Johnson & Johnson's JLABS and NVIDIA's Inception program, showcases its leadership in the field of AI technology.

• - The result? A powerful alliance committed to improving clinical trial efficiency and ultimately ensuring that life-changing therapies reach patients faster.

Conclusion: A Vision for the Future

As LabConnect and OmniScience embark on this new venture, they are set to usher in a new era of clinical trial intelligence. By bringing sophisticated AI solutions to the forefront, they are not just improving data management but are revolutionizing the clinical research landscape.